Neurotrophic and neuroimmune responses to early-life Pseudomonas aeruginosa infection in rat lungs

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 299, Issue 3, 2010, Pages

  Cardenas, Silvia ^a   Scuri, Mario ^a   Samsell, Lennie ^a   Ducatman, Barbara ^a   Bejarano, Pablo ^b   Auais, Alexander ^c   Doud, Melissa ^d   Mathee, Kalai ^d   Piedimonte, Giovanni ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c GENENTECH INC   (United States)

^d FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Cystic fibrosis; Immunodeficiency; Nerve growth factor; Neuroimmunomodulation

Indexed keywords

ALGINIC ACID; CAPSAICIN; EVANS BLUE; INTERLEUKIN 18; INTERLEUKIN 1BETA; LEPTIN; NEUROTROPHIN; ANTIBODY; AUTACOID; CARBAZOLE DERIVATIVE; CHEMOKINE; CYTOKINE; ENZYME INHIBITOR; INDOLE ALKALOID; K 252; NERVE GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; HISTOPATHOLOGY; LUNG INFECTION; NERVE STIMULATION; NEUROIMMUNOLOGY; NEUROTROPISM; NEUTROPHIL CHEMOTAXIS; NOCICEPTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; AGING; ANIMAL; CAPILLARY PERMEABILITY; DRUG ANTAGONISM; FISCHER 344 RAT; IMMUNOLOGY; IMMUNOMODULATION; INNERVATION; LUNG; LUNG CIRCULATION; LUNG DISEASE; METABOLISM; MICROBIOLOGY; MICROVASCULATURE; NEUROGENIC INFLAMMATION; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY; UPREGULATION; WEANING;

AGING; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES; CAPILLARY PERMEABILITY; CARBAZOLES; CHEMOKINES; CYTOKINES; ENZYME INHIBITORS; INDOLE ALKALOIDS; INFLAMMATION MEDIATORS; LUNG; LUNG DISEASES; MICROVESSELS; NERVE GROWTH FACTORS; NEUROGENIC INFLAMMATION; NEUROIMMUNOMODULATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PULMONARY CIRCULATION; RATS; RATS, INBRED F344; UP-REGULATION; WEANING;

EID: 77956674294     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00017.2010     Document Type: Article

References (50)

1. Arend WP, Palmer G, Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 223: 20-38, 2008.
2. Auais A, Adkins B, Napchan G, Piedimonte G. Immunomodulatory effects of sensory nerves during respiratory syncytial virus infection in rats. Am J Physiol Lung Cell Mol Physiol 285: L105-L113, 2003.
3. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17: 4-12, 2006.
4. Bessac BF, Jordt SE. Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control. Physiology (Bethesda) 23: 360-370, 2008.
5. Buck H, Winter J. K252a modulates the expression of nerve growth factor-dependent capsaicin sensitivity and substance P levels in cultured adult rat dorsal root ganglion neurones. J Neurochem 67: 345-351, 1996. (Pubitemid 26185616)
6. Chan ED, Choi HS, Cool C, Accurso FJ, Fantuzzi G. Interleukin-18 expression in cystic fibrosis lungs. Chest 121: 84S-85S, 2002.
7. Choi JY, Khansaheb M, Joo NS, Krouse ME, Robbins RC, Weill D, Wine JJ. Substance P stimulates human airway submucosal gland secretion mainly via a CFTR-dependent process. J Clin Invest 119: 1189-1200, 2009.
8. Coppola V, Barrick CA, Southon EA, Celeste A, Wang K, Chen B, Haddad el B, Yin J, Nussenzweig A, Subramaniam A, Tessarollo L. Ablation of TrkA function in the immune system causes B cell abnormalities. Development 131: 5185-5195, 2004.
9. Covas MJ, Pinto LA, Pereira Da Silva JA, Victorino RM. Effects of the neuropeptide, substance P, on lymphocyte proliferation in rheumatoid arthritis. J Int Med Res 23: 431-438, 1995.
10. Desai TJ, Cardoso WV. Growth factors in lung development and disease: friends or foe? Respir Res 3: 2, 2002.
11. Farrell PM, Li Z, Kosorok MR, Laxova A, Green CG, Collins J, Lai HC, Makholm LM, Rock MJ, Splaingard ML. Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis. Pediatr Pulmonol 36: 230-240, 2003. (Pubitemid 37055971)
12. Frederiksen B, Koch C, Hoiby N. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). Pediatr Pulmonol 28: 159-166, 1999.
13. Hoiby N, Frederiksen B, Pressler T. Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros 4: 49-54, 2005.
14. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 43: 143-201, 1991.
15. Hu C, Wedde-Beer K, Auais A, Rodriguez MM, Piedimonte G. Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs. Am J Physiol Lung Cell Mol Physiol 283: L494-L502, 2002.
16. Johansen HK, Hoiby N. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 47: 109-111, 1992.
17. King KA, Hu C, Rodriguez MM, Romaguera R, Jiang X, Piedimonte G. Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats. Am J Respir Cell Mol Biol 24: 101-107, 2001. (Pubitemid 32152070)
18. Koch C. Early infection and progression of cystic fibrosis lung disease. Pediatr Pulmonol 34: 232-236, 2002.
19. Kukavica-Ibrulj I, Levesque RC. Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies. Lab Anim 42: 389-412, 2008.
20. Lee TW, Brownlee KG, Denton M, Littlewood JM, Conway SP. Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center. Pediatr Pulmonol 37: 104-110, 2004.
21. Mantyh CR, Gates TS, Zimmerman RP, Welton ML, Passaro EP Jr, Vigna SR, Maggio JE, Kruger L, Mantyh PW. Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease. Proc Natl Acad Sci USA 85: 3235-3239, 1988.
22. Mantyh PW, Catton MD, Boehmer CG, Welton ML, Passaro EP Jr, Maggio JE, Vigna SR. Receptors for sensory neuropeptides in human inflammatory diseases: implications for the effector role of sensory neurons. Peptides 10: 627-645, 1989.
23. McDonald DM, Schoeb TR, Lindsey JR. Mycoplasma pulmonis infections cause long-lasting potentiation of neurogenic inflammation in the respiratory tract of the rat. J Clin Invest 87: 787-799, 1991.
24. Mohtasham L, Auais A, Piedimonte G. Nerve growth factor mediates steroid-resistant inflammation in respiratory syncytial virus infection. Pediatr Pulmonol 42: 496-504, 2007. (Pubitemid 46870380)
25. Moss RB. Pathophysiology and immunology of allergic bronchopulmonary aspergillosis. Med Mycol 43, Suppl 1: S203-S206, 2005.
26. Nichols D, Chmiel J, Berger M. Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling. Clin Rev Allergy Immunol 34: 146-162, 2008.
27. Ohmichi M, Decker SJ, Pang L, Saltiel AR. Inhibition of the cellular actions of nerve growth factor by staurosporine and K252A results from the attenuation of the activity of the trk tyrosine kinase. Biochemistry 31: 4034-4039, 1992.
28. Othumpangat S, Gibson LF, Samsell L, Piedimonte G. NGF is an essential survival factor for bronchial epithelial cells during respiratory syncytial virus infection. PLoS One 4: e6444, 2009.
29. Pedersen SS, Shand GH, Hansen BL, Hansen GN. Induction of experimental chronic Pseudomonas aeruginosa lung infection with P. aeruginosa entrapped in alginate microspheres. APMIS 98: 203-211, 1990.
30. Piedimonte G. Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae. Am J Respir Crit Care Med 163: S18-S21, 2001.
31. Piedimonte G. Pathophysiological mechanisms for the respiratory syncytial virus-reactive airway disease link. Respir Res 3, Suppl 1: S21-S25, 2002.
32. Piedimonte G, Hegele RG, Auais A. Persistent airway inflammation after resolution of respiratory syncytial virus infection in rats. Pediatr Res 55: 657-665, 2004.
33. Piedimonte G, Nadel JA, Umeno E, McDonald DM. Sendai virus infection potentiates neurogenic inflammation in the rat trachea. J Appl Physiol 68: 754-760, 1990.
34. Piedimonte G, Pickles RJ, Lehmann JR, McCarty D, Costa DL, Boucher RC. Replication-deficient adenoviral vector for gene transfer potentiates airway neurogenic inflammation. Am J Respir Cell Mol Biol 16: 250-258, 1997. (Pubitemid 127497447)
35. Piedimonte G, Rodriguez MM, King KA, McLean S, Jiang X. Respiratory syncytial virus upregulates expression of the substance P receptor in rat lungs. Am J Physiol Lung Cell Mol Physiol 277: L831-L840, 1999.
36. Rabin HR, Butler SM, Wohl ME, Geller DE, Colin AA, Schidlow DV, Johnson CA, Konstan MW, Regelmann WE. Pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol 37: 400-406, 2004.
37. Rubin JS, Bradshaw R. Isolation and partial amino acid sequence analysis of nerve growth factor from guinea pig prostate. J Neurosci Res 6: 451-464, 1981.
38. Saria A, Lundberg JM, Skofitsch G, Lembeck F. Vascular protein leakage in various tissue induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge. Naunyn Schmiedebergs Arch Pharmacol 324: 212-218, 1983. (Pubitemid 14247789)
39. Schuijers JA, Walker DW, Browne CA, Thorburn GD. Peripheral and brain tissue catecholamine content in intact and anti-NGF-treated fetal sheep. Am J Physiol Regul Integr Comp Physiol 252: R7-R12, 1987.
40. Skinner ML, Schlosser RJ, Lathers D, Neal JG, Woodworth BA, Hall J, Newton DA, Baatz JE. Innate and adaptive mediators in cystic fibrosis and allergic fungal rhinosinusitis. Am J Rhinol 21: 538-541, 2007.
41. Song Z, Moser C, Wu H, Faber V, Kharazmi A, Hoiby N. Cytokine modulating effect of ginseng treatment in a mouse model of Pseudomonas aeruginosa lung infection. J Cyst Fibros 2: 112-119, 2003.
42. Song Z, Wu H, Mathee K, Hoiby N, Kharazmi A. Gerimax ginseng regulates both humoral and cellular immunity during chronic Pseudomonas aeruginosa lung infection. J Altern Complement Med 8: 459-466, 2002.
43. Stylianou C, Galli-Tsinopoulou A, Koliakos G, Fotoulaki M, Nousia- Arvanitakis S. Ghrelin and leptin levels in young adults with cystic fibrosis: relationship with body fat. J Cyst Fibros 6: 293-296, 2007. (Pubitemid 46971895)
44. Taccetti G, Campana S, Festini F, Mascherini M, Doring G. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients. Eur Respir J 26: 458-461, 2005.
45. Tortorolo L, Langer A, Polidori G, Vento G, Stampachiacchere B, Aloe L, Piedimonte G. Neurotrophin overexpression in lower airways of infants with respiratory syncytial virus infection. Am J Respir Crit Care Med 172: 233-237, 2005.
46. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 47: 1-9, 1980.
47. Wilfong ER, Dey RD. Nerve growth factor and substance P regulation in nasal sensory neurons after toluene diisocyanate exposure. Am J Respir Cell Mol Biol 30: 793-800, 2004.
48. Yokoyama MM, Fujimoto K. Role of lymphocyte activation by substance P in rheumatoid arthritis. Int J Tissue React 12: 1-9, 1990. (Pubitemid 20296047)
49. Zar JH. Biostatistical Analysis. Englewood Cliffs, NJ: Prentice-Hall, 1984.
50. 1 heat-gated ion channels. EMBO J 24: 4211-4223, 2005.